Abstract
Aim:
To determine the frequencies of polymorphism and haplotype in the transforming growth factor-beta 1 (TGF-β1) gene promoter in the Chinese population and to investigate the susceptibility of this population to chronic obstructive pulmonary disease (COPD).
Methods:
The target fragments of the TGF-β1 gene promoter were amplified and analyzed by polymerase chain reaction-restriction fragment length polymorphism technique in 84 COPD patients and 97 age- and sex-matched healthy controls. The test for Hardy-Weinberg equilibrium was performed using HWE program of the LINKUTIL package and statistical analysis was carried out with the SPSS statistical package. An expectation maximization algorithm was used for the pairwise linkage disequilibrium test and haplotype analysis.
Results:
More carriers of the -800A allele, or fewer carriers of the -509T allele, were detected in the COPD patients compared with the non-symptomatic control subjects [for the -800A allele, 29.8% vs 14.4%, respectively, χ2=6.257, degrees of freedom (df)=1, P=0.012; for the -509T allele, 27.3% vs 44.3%, respectively, χ2=5.582, df=1, P=0.018]. The prevalence of the -800A allele was significantly higher in the COPD patients than in control subjects (P=0.009), whereas the frequency of the -509T allele was significantly higher in control subjects than in the COPD patients (P=0.008). In addition, this distribution tendency for the -800A or -509T allele was similar in heavy smokers (smoking history ≥20 pack years); (number of packs of cigarettes per day multiplied by the number of years of smoking) χ2=7.235, P=0.007, and χ2=5.636, P=0.018, respectively). The linkage disequilibrium was found between -800 G→A and -509 C→T (D<0.60, P < 0.0001), and the frequency of the AC haplotype, consisting of the least common base at -800 and the most common base at -509, was significantly higher in patients with COPD than in controls (0.056 vs 0.021, P<0.05).
Conclusion:
The single nucleotide polymorphism (SNP) in the TGF-β1 gene promoter might be associated with COPD, and the -800A/-509C haplotype is possibly one of the susceptibility factors for COPD.
Similar content being viewed by others
Article PDF
References
Davis RM, Novotny TE . The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: S82–S84.
Molfino NA . Impact of basic research on tomorrow's medicine: genetics of COPD. Chest 2004; 125: 1929–40.
Kauffmann F, Tager IB, Munoz A, Speizer FE . Familial factors related to lung function in children aged 6–10 years. Results from the PAARC epidemiologic study. Am J Epidemiol 1989; 129: 1289–99.
Poller W, Meison C, Olek K . DNA polymorphisms of the β1–antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest 1990; 20: 1–7.
Samilchuk EI, Chuchalin AG . Mis-sense mutation of α1–antichymotrypsin gene and chronic lung disease [letter]. Lancet 1993; 342: 624.
Smith CAD, Harrison DJ . Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630–33.
Schellenberg D, Pare PD, Weir TD, Spinelli JJ, Walker BAM, Sandford AJ . Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998; 157: 957–61.
Huang SL, Su CH, Chang SC . Tumor necrosis factor-agene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436–9.
Massague, J . The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6: 597–641.
Lyons RM, Gentry LE, Purchio AF, Moses HL . Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 1990; 110: 1361–7.
Lyons RM, Keski-Oja J, Moses HL . Proteolytic activation of latent transforming growth factor-beta from fibroblast conditioned medium. J Cell Biol 1988; 106: 1659–65.
Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–5.
Watanabe Y, Kinoshita A, Yamada T, Ohta T, Kishino T, Matsumoto N, et al. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-β1 (TGF-β1) and its signaling pathway. J Hum Genet 2002; 47: 478–83.
Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, et al. Polymorphisms of the TGF-β1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881–7.
Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, et al. Transforming growth factor-β1 gene polymorphisms and coronary artery disease. Clin Sci 1998; 95: 659–67.
Wu L, Chau J, Young RP, Pokony V, Mills GD, Hopkins R, et al. Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59: 126–9.
Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J, et al. Transforming growth factor-β1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004; 169: 214–19.
Miller SA, Dykes DD, Polesky HF . A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
Xie X, Ott J . Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 1993; 53: 1107.
Zhao JH, Curtis D, Sham PC . Model-free analysis and permutation test for allelic associations. Hum Hered 2000; 50: 133–39.
Zhao JH . 2LD- two-locus linkage disequilibrium (LD) calculator. [cited 2002] Available from: http://www.iop.kcl.ac.uk/IoP/Departments/PsychMed/GEpiBSt/software.shtml.
Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 1999; 8: 93–7.
Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, et al. Loss of integrin αvβ6 mediated TGF-β activation causes MMP12-dependent emphysema. Nature 2003; 422: 169–73.
Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L . Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158: 1958–62.
Pulleyn LJ, Newton R, Adcock IM, Barnes PJ . TGFβ1 allele association with asthma severity. Hum Genet 2001; 109: 623–7.
Pratsinis H, Giannouli CC, Zervolea I, Psarras S, Stathakos D, Kletsas D . Differential proliferative response of fetal and adult human skin fibroblasts to transforming growth factor-beta. Wound Repair Regen 2004; 12: 374–83.
Derynck R, Akhurst RJ, Balmain A . TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117–29.
Ravanti L, Häkkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J, et al. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase J Biol Chem 1999; 274: 37 292–300.
Leivonen SK, Chantry A, Häkkinen L, Han J, Kähäri VM . Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. J Biol Chem 2002; 277: 46 338–46.
Eickelberg O, Kohler E, Reichenberger F, Bertschin S, Woodtli T, Erne P, et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 1999; 276 ( 5 Pt 1): L814–24.
Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH . Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol 1999; 162: 5528–35.
McGowan SE, Jackson SK, Olson PJ, Parekh T, Gold LI . Exogenous and endogenous transforming growth factors-beta influence elastin gene expression in cultured lung fibroblasts. Am J Respir Cell Mol Biol 1997; 17: 25–35.
Kucich U, Rosenbloom JC, Abrams WR, Rosenbloom J . Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. Am J Respir Cell Mol Biol 2002; 26: 183–8.
Celedon JC, Lange C, Raby BA, Litonjua AA, Palmer LJ, DeMeo DL, et al. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 2004; 13: 1649–56.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30200161 and No 30370628).
Rights and permissions
About this article
Cite this article
Su, Zg., Wen, Fq., Feng, Yl. et al. Transforming growth factor-β1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol Sin 26, 714–720 (2005). https://doi.org/10.1111/j.1745-7254.2005.00085.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00085.x